# Effects of Nasal-spraying LiveSpo Navax in Treatment of Influenza Virus in Children

> **NCT05378022** · NA · COMPLETED · sponsor: **National Children's Hospital, Vietnam** · enrollment: 70 (actual)

## Conditions studied

- Acute Respiratory Tract Infections

## Interventions

- **COMBINATION_PRODUCT:** LiveSpo Navax
- **DRUG:** 0.9% NaCl physiological saline

## Key facts

- **NCT ID:** NCT05378022
- **Lead sponsor:** National Children's Hospital, Vietnam
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-21
- **Primary completion:** 2022-03-31
- **Final completion:** 2022-04-22
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2022-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05378022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05378022, "Effects of Nasal-spraying LiveSpo Navax in Treatment of Influenza Virus in Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05378022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*